CBLB and neoplasm: Consistently, ACT of cblb-deficient hyperactive polyclonal CD8+ T cells into fully immune-competent animals in combination with a dendritic cell (DC) vaccine markedly delayed tumor outgrowth and substantially improved survival rates [21].